Sage is a Massachusetts-based biotechnology firm that researches, develops and commercialises novel therapies for the treatment of CNS and neurodegenerative disorders... Read more
Sage is a Massachusetts-based biotechnology firm that researches, develops and commercialises novel therapies for the treatment of CNS and neurodegenerative disorders... Read more
2010
PublicAcquired by Supernus Pharmaceuticals, Inc.NASDAQSAGE
News
Sep 25, 2026
Law 360
Sage Therapeutics: SEC Says Md. Woman Illegally Traded On FDA Approval Info
Apr 21, 2026
BioPharma Dive
Sage Therapeutics: Tortugas debuts with $106M and brain drugs from Hansoh, Eisai
Jan 27, 2026
Bloomberg Law
Sage Therapeutics: Boston Man to Settle SEC Insider Trading Case Over Drug Denial
Aug 01, 2025
Pharamceutical Technology
Sage Therapeutics: Supernus strengthens neuropsychiatric portfolio with Sage Therapeutics
Jul 31, 2025
Citybizlist
Sage Therapeutics: Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics
Jul 31, 2025
Owler
Sage Therapeutics, Inc.: Sage Therapeutics's revenue changed from $47.40M in Mar 2025 to $70.41M in Jun 2025
Jul 28, 2025
Investing.com
Sage Therapeutics: Supernus gets regulatory clearance for Sage acquisition By Investing.com
Jul 11, 2025
PR-Inside
Press Release: Sage Therapeutics : SAGE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale ...
Jul 01, 2025
Benzinga
Sage Therapeutics: $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Sage Therapeutics, Inc. (NASDAQ: SAGE)
Jun 30, 2025
BioSpace
Sage Therapeutics: Sage Sacks Entire Staff After Supernus Buyout
